Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2011 072 947.0 |
96 | EP file number | EAKZ | 21 20 5422.5 |
97 | EP publication number | EPN | 3981427 |
54 | Designation/title | TI | PEGYLIERTE LIPOSOMEN ZUR AUSLIEFERUNG VON IMMUNOGEN-KODIERENDER RNS |
51 | IPC main class | ICM (ICMV) | A61K 39/39 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/12 (2006.01), A61K 9/127 (2025.01) |
22 | DE application date | DAT | Aug 31, 2011 |
96 | EP application date | EAT | Aug 31, 2011 |
43 | Date of first publication | OT | Apr 13, 2022 |
| Date of publication of grant | PET | May 25, 2022 |
71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals S.A., Rixensart, BE |
72 | Inventor | IN | GEALL, Andrew, Emeryville, 94662-8097, US; VERMA, Ayush, Emeryville, 94662-8097, US |
74 | Representative | VTR | Müller Schupfner & Partner Patent- und Rechtsanwaltspartnerschaft mbB, 80336 München, DE |
| Address for service | | Müller Schupfner & Partner Patent- und Rechtsanwaltspartnerschaft mbB, 80336 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 37882610 P Aug 31, 2010
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003981427A1 Searchable text:
EP000003981427A1 Original document:
EP000003981427B1 Searchable text:
EP000003981427B1 |
43 | Date of first publication | EVT | Apr 13, 2022 |
| Date of the first transfer into DPMAregister | EREGT | Apr 13, 2022 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 13, 2025 (Show all update days)(Hide all update days)- Mar 13, 2025
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 31.10.2024: changed
- Feb 6, 2025
- Status: changed
- Due date: deleted
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 31.10.2024: new
- Procedures: Opposition procedure, Revocation by EPO, 31.10.2024: new
- Dec 5, 2024
- IPC secondary class(es): changed
- Jul 30, 2024
- Jul 29, 2023; Mar 23, 2023; Mar 6, 2023; Aug 5, 2022; Jun 1, 2022; May 25, 2022; May 6, 2022; May 4, 2022
- Historical data not available for this/these date(s)
- Apr 13, 2022
- Date of the first transfer into DPMAregister
|